Investigational Site Number: 4100001

Seoul 6591

1 studies enrolling now · 8 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Crohn's Disease, Dermatitis Atopic, Glycogen Storage Disease Type II;Pompe's Disease, Non-small Cell Lung Cancer Metastatic, Polycystic Kidney, Autosomal Dominant, Sjogren's Syndrome, Sjögren's Syndrome, Type 2 Diabetes Mellitus

Studies at this site

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients — Stopped early
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) — Completed
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling
• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed
• A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients — Stopped early
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early